{"id":"https://openalex.org/W25071997","doi":null,"title":"Gemcitabine and docetaxel in metastatic breast cancer.","display_name":"Gemcitabine and docetaxel in metastatic breast cancer.","publication_year":2004,"publication_date":"2004-12-01","ids":{"openalex":"https://openalex.org/W25071997","mag":"25071997","pmid":"https://pubmed.ncbi.nlm.nih.gov/15685820"},"language":"en","primary_location":{"id":"pmid:15685820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15685820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020083811","display_name":"Andrew David Seidman","orcid":"https://orcid.org/0000-0002-5064-3966","observed_orcids":["https://orcid.org/0000-0002-5064-3966"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew D Seidman","raw_affiliation_strings":["Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. seidmana@mskcc.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Breast Cancer Medicine Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. seidmana@mskcc.org","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5020083811"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":null,"apc_paid":null,"fwci":0.3676,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.63073754,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"18","issue":"14 Suppl 12","first_page":"13","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.026200000196695328,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9890000224113464},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":1.0},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8370000123977661},{"id":"https://openalex.org/keywords/anthracycline-pretreated-patients","display_name":"anthracycline-pretreated patients","score":0.8009999990463257},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7120000123977661},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.949999988079071},{"id":"https://openalex.org/keywords/growth-factor-support","display_name":"growth factor support","score":0.8309999704360962},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.8489999771118164},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.9739552140235901},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9340859651565552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8609895706176758},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.7436882257461548},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7343870997428894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5735340118408203},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.4935053586959839},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.48533669114112854},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4814388155937195},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4813009798526764},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4265693128108978},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4259006679058075},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34718817472457886},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29489967226982117}],"mesh":[{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15685820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15685820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},{"id":"mag:25071997","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15685820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":70,"referenced_works":["https://openalex.org/W1499972543","https://openalex.org/W1691933867","https://openalex.org/W1907604566","https://openalex.org/W1976487179","https://openalex.org/W1977479611","https://openalex.org/W1989889539","https://openalex.org/W2000935408","https://openalex.org/W2005538890","https://openalex.org/W2006461851","https://openalex.org/W2010105907","https://openalex.org/W2014134856","https://openalex.org/W2014159231","https://openalex.org/W2017927352","https://openalex.org/W2020585096","https://openalex.org/W2020622202","https://openalex.org/W2031708286","https://openalex.org/W2033214224","https://openalex.org/W2035551334","https://openalex.org/W2037362492","https://openalex.org/W2044822064","https://openalex.org/W2046178499","https://openalex.org/W2054178968","https://openalex.org/W2058402458","https://openalex.org/W2060485250","https://openalex.org/W2062488744","https://openalex.org/W2065703573","https://openalex.org/W2072970694","https://openalex.org/W2073031950","https://openalex.org/W2078005482","https://openalex.org/W2080283023","https://openalex.org/W2089046092","https://openalex.org/W2089770020","https://openalex.org/W2092509147","https://openalex.org/W2097190202","https://openalex.org/W2098686923","https://openalex.org/W2099859380","https://openalex.org/W2100189539","https://openalex.org/W2108703094","https://openalex.org/W2113281257","https://openalex.org/W2116265343","https://openalex.org/W2121148773","https://openalex.org/W2121748291","https://openalex.org/W2124603307","https://openalex.org/W2126942676","https://openalex.org/W2128769815","https://openalex.org/W2130631008","https://openalex.org/W2131770017","https://openalex.org/W2134123776","https://openalex.org/W2135537964","https://openalex.org/W2136995411","https://openalex.org/W2139661911","https://openalex.org/W2141056749","https://openalex.org/W2150067367","https://openalex.org/W2152777704","https://openalex.org/W2157540911","https://openalex.org/W2157880517","https://openalex.org/W2158256604","https://openalex.org/W2161802079","https://openalex.org/W2166637116","https://openalex.org/W2167084464","https://openalex.org/W2168312648","https://openalex.org/W2183652117","https://openalex.org/W2324938023","https://openalex.org/W2376751074","https://openalex.org/W2411049219","https://openalex.org/W2414469356","https://openalex.org/W4211010778","https://openalex.org/W4243003655","https://openalex.org/W6685783919","https://openalex.org/W6703523346"],"related_works":["https://openalex.org/W2051530062","https://openalex.org/W2415253097","https://openalex.org/W2020622202","https://openalex.org/W4245082910","https://openalex.org/W3009768241","https://openalex.org/W2414066636","https://openalex.org/W2124697776","https://openalex.org/W2004842027","https://openalex.org/W2288325587","https://openalex.org/W2129979963"],"abstract_inverted_index":{"Use":[0],"of":[1,19,21,32,45,109,127,137,180,195,206,269,278],"the":[2,16,22,177,181],"gemcitabine":[3,46,75,138,221],"(Gemzar)":[4],"plus":[5,230,251],"docetaxel":[6,58,86,148,231,252],"(Taxotere)":[7],"combination":[8],"in":[9,35,113,125,167,172,183,262,281],"metastatic":[10,265],"breast":[11,266],"cancer":[12],"is":[13,176,219],"motivated":[14],"by":[15],"different":[17],"mechanisms":[18],"action":[20],"drugs,":[23],"partially":[24],"nonoverlapping":[25],"toxicity":[26,179],"profiles,":[27],"and":[28,37,55,57,83,85,94,147,170,204,228],"good":[29],"single-agent":[30],"activities":[31],"both":[33],"drugs":[34],"treatment-naive":[36,173],"anthracycline-pretreated":[38],"patients.":[39,174],"In":[40,130],"phase":[41,131,184,216],"II":[42,132,185],"trials,":[43],"combinations":[44,280],"at":[47,59,76,87,139,149,222,232,243,253],"900":[48],"or":[49,68,74,96,141,151,157,189],"1,000":[50,223,244],"mg/m2":[51,63,78,89,98,143,153,159,224,234,245,255],"on":[52,64,79,90,99,144,154,160,225,235,256],"days":[53,80,91,226,250,261],"1":[54,67,101,146,156,227,237,258],"8":[56,70,229],"75":[60,233,254],"to":[61,111,202,212,274],"100":[62,97],"either":[65],"day":[66,69,100,145,155,161,236,257],"every":[71,102,238,259],"3":[72],"weeks,":[73,104],"800":[77],"1,":[81,92],"8,":[82,93,162],"15":[84,95],"35":[88],"4":[103],"have":[105],"produced":[106],"response":[107,119,163],"rates":[108,120,164,194,205],"36%":[110],"79%":[112,203],"patients":[114,169,263,282],"receiving":[115],"primarily":[116],"second-line":[117],"treatment;":[118],"were":[121,165],"greater":[122],"than":[123],"50%":[124,166],"five":[126],"six":[128],"studies.":[129],"trials":[133],"using":[134],"every-2-week":[135],"regimens":[136],"1,500":[140],"2,000":[142],"50":[150],"65":[152],"55":[158],"pretreated":[168],"66%":[171],"Neutropenia":[175],"primary":[178],"combination;":[182],"studies":[186],"performed":[187],"with":[188,264,283],"without":[190],"growth":[191],"factor":[192],"support,":[193],"grade":[196],"3/4":[197],"neutropenia":[198,208],"ranged":[199,209],"from":[200,210],"29%":[201],"febrile":[207],"0%":[211],"18%.":[213],"An":[214],"ongoing":[215],"III":[217],"trial":[218,271],"comparing":[220],"21":[239,260],"days,":[240],"vs":[241],"capecitabine":[242],"twice":[246],"daily":[247],"for":[248],"14":[249],"cancer.":[267],"Results":[268],"this":[270],"will":[272],"help":[273],"determine":[275],"optimal":[276],"use":[277],"taxane-based":[279],"advanced":[284],"disease.":[285]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}